CAR T-cell Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Publish Date: Sep 2021

Report Code: TMR2496A

Publisher: Transparency

Download Report Overview

Single User License: $5795

Explore Our Services

Already a member? Login here.

Sample Report

Report Highlights

CAR T-cell Therapy Market – Scope of Report

TMR’s report on the global CAR T-cell therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global CAR T-cell therapy market for the period of 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global CAR T-cell therapy market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the CAR T-cell therapy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global CAR T-cell therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global CAR T-cell therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global CAR T-cell therapy market.

The report delves into the competitive landscape of the global CAR T-cell therapy market. Key players operating in the global CAR T-cell therapy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global CAR T-cell therapy market profiled in this report.

Key Questions Answered in CAR T-cell Therapy Market Report

What is the sales/revenue generated by CAR T-cell therapy across all regions during the forecast period?
What are the opportunities in the global CAR T-cell therapy market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which product type is expected to generate the highest revenue globally in 2031? Which segment is projected to expand at the highest CAGR during the forecast period?
What is the market position of different companies operating in the global market?

CAR T-cell Therapy Market – Research Objectives and Research Approach

The comprehensive report on the global CAR T-cell therapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global CAR T-cell therapy market in terms of product type, indication, end-user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global CAR T-cell therapy market.

Table 1 : Global Car T-Cell Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 2 : Global Car T-Cell Therapy Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 3 : Global Car T-Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 4 : Global Car T-Cell Therapy Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 5 : North America CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 6 : North America CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 7 : North America CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 8 : North America CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 9 : Europe CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10 : Europe CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 11 : Europe CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 12 : Europe CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13 : Asia Pacific CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14 : Asia Pacific CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 15 : Asia Pacific CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 16 : Asia Pacific CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17 : Latin America CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18 : Latin America CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 19 : Latin America CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 20 : Latin America CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21 : Middle East & Africa CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22 : Middle East & Africa CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 23 : Middle East & Africa CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 24 : Middle East & Africa CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Figure 1 : Global CAR T-cell Therapy Market Value (US$ Mn) Forecast, 2017–2031
Figure 2 : Global CAR T-cell Therapy Market Value Share, by Product Type, 2020
Figure 3 : Global CAR T-cell Therapy Market Value Share, by Indication, 2020
Figure 4 : Global CAR T-cell Therapy Market Value Share, by End-user Type, 2020
Figure 5 : Global CAR T-cell Therapy Market Value Share, by Region, 2020
Figure 6 : Global Car T-Cell Therapy Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 7 : Global Car T-Cell Therapy Market Value (US$ Mn), by Axicabtagene Ciloleucel, 2017–2031
Figure 8 : Global Car T-Cell Therapy Market Value (US$ Mn), by Tisagenlecleucel, 2017–2031
Figure 9 : Global Car T-Cell Therapy Market Value (US$ Mn), by Brexucabtagene Autoleucel, 2017–2031
Figure 10 : Global Car T-Cell Therapy Market Value (US$ Mn), by Lisocabtagene Maraleucel, 2017–2031
Figure 11 : Global Car T-Cell Therapy Market Value (US$ Mn), by Idecabtagene Vicleucel, 2017–2031
Figure 12 : Global Car T-Cell Therapy Market Value (US$ Mn), by Others, 2017–2031
Figure 13 : Global Car T-Cell Therapy Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 14 : Global Car T-Cell Therapy Market Value Share Analysis, by Indication, 2020 and 2031
Figure 15 : Global Car T-Cell Therapy Market Value (US$ Mn), by Acute Lymphocytic Leukemia, 2017–2031
Figure 16 : Global Car T-Cell Therapy Market Value (US$ Mn), by Diffuse Large B-cell Lymphoma, 2017–2031
Figure 17 : Global Car T-Cell Therapy Market Value (US$ Mn), by Follicular Lymphoma, 2017–2031
Figure 18 : Global Car T-Cell Therapy Market Value (US$ Mn), by Mantle Cell Lymphoma, 2017–2031
Figure 19 : Global Car T-Cell Therapy Market Value (US$ Mn), by Multiple Myeloma, 2017–2031
Figure 20 : Global Car T-Cell Therapy Market Attractiveness Analysis, by Indication, 2021–2031
Figure 21 : Global Car T-Cell Therapy Market Value Share Analysis, by End-user, 2020 and 2031
Figure 22 : Global Car T-Cell Therapy Market Value (US$ Mn), by Hospitals, 2017–2031
Figure 23 : Global Car T-Cell Therapy Market Value (US$ Mn), by Cancer Treatment Centers, 2017–2031
Figure 24 : Global Car T-Cell Therapy Market Attractiveness Analysis, by End-user, 2021–2031
Figure 25 : Global Car T-Cell Therapy Market Value Share Analysis, by Region, 2020 and 2031
Figure 26 : Global Car T-Cell Therapy Market Attractiveness Analysis, by Region, 2021-2031
Figure 27 : North America CAR T-Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 28 : North America CAR T-Cell Therapy Market Value Share (%), by Country, 2020 and 2031
Figure 29 : North America CAR T-Cell Therapy Market Attractiveness Analysis, by Country, 2021–2031
Figure 30 : North America CAR T-Cell Therapy Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 31 : North America CAR T-Cell Therapy Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 32 : North America CAR T-Cell Therapy Market Value Share Analysis, by Indication, 2020 and 2031
Figure 33 : North America CAR T-Cell Therapy Market Attractiveness Analysis, by Indication, 2021–2031
Figure 34 : North America CAR T-Cell Therapy Market Value Share Analysis, by End-user, 2020 and 2031
Figure 35 : North America CAR T-Cell Therapy Market Attractiveness Analysis, by End-user, 2021–2031
Figure 36 : Europe CAR T-Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 37 : Europe CAR T-Cell Therapy Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 38 : Europe CAR T-Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 39 : Europe CAR T-Cell Therapy Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 40 : Europe CAR T-Cell Therapy Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 41 : Europe CAR T-Cell Therapy Market Value Share Analysis, by Indication, 2020 and 2031
Figure 42 : Europe CAR T-Cell Therapy Market Attractiveness Analysis, by Indication, 2021–2031
Figure 43 : Europe CAR T-Cell Therapy Market Value Share Analysis, by End-user, 2020 and 2031
Figure 44 : Europe CAR T-Cell Therapy Market Attractiveness Analysis, by End-user, 2021–2031
Figure 45 : Asia Pacific CAR T-Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 46 : Asia Pacific CAR T-Cell Therapy Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 47 : Asia Pacific CAR T-Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 48 : Asia Pacific CAR T-Cell Therapy Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 49 : Asia Pacific CAR T-Cell Therapy Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 50 : Asia Pacific CAR T-Cell Therapy Market Value Share Analysis, by Indication, 2020 and 2031
Figure 51 : Asia Pacific CAR T-Cell Therapy Market Attractiveness Analysis, by Indication, 2021–2031
Figure 52 : Asia Pacific CAR T-Cell Therapy Market Value Share Analysis, by End-user, 2020 and 2031
Figure 53 : Asia Pacific CAR T-Cell Therapy Market Attractiveness Analysis, by End-user, 2021–2031
Figure 54 : Latin America CAR T-Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 55 : Latin America CAR T-Cell Therapy Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 56 : Latin America CAR T-Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 57 : Latin America CAR T-Cell Therapy Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 58 : Latin America CAR T-Cell Therapy Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 59 : Latin America CAR T-Cell Therapy Market Value Share Analysis, by Indication, 2020 and 2031
Figure 60 : Latin America CAR T-Cell Therapy Market Attractiveness Analysis, by Indication, 2021–2031
Figure 61 : Latin America CAR T-Cell Therapy Market Value Share Analysis, by End-user, 2020 and 2031
Figure 62 : Latin America CAR T-Cell Therapy Market Attractiveness Analysis, by End-user, 2021–2031
Figure 63 : Middle East & Africa CAR T-Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 64 : Middle East & Africa CAR T-Cell Therapy Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 65 : Middle East & Africa CAR T-Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 66 : Middle East & Africa CAR T-Cell Therapy Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 67 : Middle East & Africa CAR T-Cell Therapy Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 68 : Middle East & Africa CAR T-Cell Therapy Market Value Share Analysis, by Indication, 2020 and 2031
Figure 69 : Middle East & Africa CAR T-Cell Therapy Market Attractiveness Analysis, by Indication, 2021–2031
Figure 70 : Middle East & Africa CAR T-Cell Therapy Market Value Share Analysis, by End-user, 2020 and 2031
Figure 71 : Middle East & Africa CAR T-Cell Therapy Market Attractiveness Analysis, by End-user, 2021–2031
Figure 72 : Pfizer, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 73 : Pfizer, Inc., Breakdown of Net Sales (%), by Biopharma Segment, 2020
Figure 74 : Pfizer, Inc., Breakdown of Net Sales (%) Region/Country, 2020
Figure 75 : Pfizer, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 76 : Novartis AG, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 77 : Novartis AG, Revenue Breakdown of Net Sales (%), by Business Segment, 202
Figure 78 : Novartis AG, Breakdown of Net Sales (%), by Region/Country, 2020
Figure 79 : Novartis AG, R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 80 : Bristol-Myers Squibb, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017 –2020
Figure 81 : Bristol-Myers Squibb, Breakdown of Net Sales (%), by Region/Country, 2020
Figure 82 : Bristol-Myers Squibb, R&D Expenses (US$ Mn) 2017–2020
Figure 83 : Amgen, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 84 : Amgen, Inc. Breakdown of Net Sales (%), by Region/Country, 2020
Figure 85 : Amgen, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 86 : Sorrento Therapeutics, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 87 : Sorrento Therapeutics, Inc. Breakdown of Net Sales (%), by Business Segment, 2020
Figure 88 : Sorrento Therapeutics, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 89 : Johnson & Johnson Services, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 90 : Johnson & Johnson Services, Inc., Breakdown of Net Sales (%), by Business Segment (Pharmaceutical), 2020
Figure 91 : Johnson & Johnson Services, Inc., Breakdown of Net Sales (%), by Region/Country, 2020
Figure 92 : Johnson & Johnson Services, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth, 2017–2020
Figure 93 : Gilead Sciences, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 94 : Gilead Sciences, Inc., Breakdown of Net Sales (%), by Region/Country, 2020
Figure 95 : Gilead Sciences, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 96 : Merck & Co., Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 97 : Merck & Co., Inc., Breakdown of Net Sales (%), by Business Segment, 2020
Figure 98 : Merck & Co., Inc., Breakdown of Net Sales (%), by Region/Country, 2020
Figure 99 : Merck & Co., Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth, 2017–2020
Figure 100 : bluebird bio, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 101 : bluebird bio, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth, 2017–2020

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

FAQ

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More

CAR T-cell Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Report Highlights

Related Reports

Recent Reports

Top Trending Reports

Become A Member

Custom Consulting

Scorecard

Innovation Spotlight